-
Posted by
Two Blokes Jul 11 -
Filed in
Stock
-
8 views
Extraordinary General Meeting of Helix Shareholders Scheduled for August 4, 2025 SOUTH SAN FRANCISCO & BOSTON, July 11, 2025 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. II (“ Helix ”) (Nasdaq: HLXB), a special purpose acquisition company (“ SPAC ”) sponsored by Cormorant Asset Management, and TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics) (“ BBOT ”), a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies, today announced that the registration statement on Form S-4 (File No. 333-288222) (as amended, the “ Registration Statement ”), filed by Helix and BBOT, relating to the previously-announced business combination among Helix, BBOT, and the other parties thereto (the “ Business Combination ”), has been declared effective by the U.S. Securities and Exchange Commission (“ SEC ”).
